OPPENHEIMER ASSET MANAGEMENT INC. - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$329,911
-22.2%
17,165
+2.9%
0.01%
-16.7%
Q2 2023$424,056
-21.1%
16,682
+12.2%
0.01%
-25.0%
Q1 2023$537,587
-7.2%
14,871
+1.6%
0.01%
-11.1%
Q4 2022$579,506
+36.0%
14,634
+60.0%
0.01%
+12.5%
Q3 2022$426,000
-30.8%
9,149
-34.9%
0.01%
-20.0%
Q2 2022$616,000
-30.5%
14,060
+14.8%
0.01%
-23.1%
Q1 2022$886,000
-1.7%
12,246
+10.1%
0.01%
+8.3%
Q4 2021$901,000
-49.3%
11,118
-27.2%
0.01%
-52.0%
Q3 2021$1,778,000
-32.2%
15,272
-3.5%
0.02%
-32.4%
Q2 2021$2,624,000
+29.7%
15,829
+9.1%
0.04%
+19.4%
Q1 2021$2,023,000
-16.3%
14,506
+3.9%
0.03%
-22.5%
Q4 2020$2,417,000
+20.4%
13,960
-3.2%
0.04%
+2.6%
Q3 2020$2,008,000
+30.4%
14,416
+11.9%
0.04%
+21.9%
Q2 2020$1,540,000
+65.9%
12,888
+38.9%
0.03%
+39.1%
Q1 2020$928,000
-23.1%
9,277
-9.6%
0.02%
-8.0%
Q4 2019$1,206,000
+19.8%
10,264
-12.4%
0.02%
+13.6%
Q3 2019$1,007,000
+56.1%
11,718
+17.8%
0.02%
+57.1%
Q2 2019$645,000
+15.6%
9,949
+11.4%
0.01%
+7.7%
Q1 2019$558,000
+393.8%
8,930
+206.5%
0.01%
+333.3%
Q4 2018$113,000
+61.4%
2,914
+281.4%
0.00%
+50.0%
Q3 2017$70,000
+20.7%
764
-1.5%
0.00%0.0%
Q2 2017$58,000
+176.2%
776
+248.0%
0.00%
+100.0%
Q1 2017$21,0002230.00%
Other shareholders
NEVRO CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders